Gedeon Richter Plc. Announces Positive Phase IIIb Top-line Results of Cariprazine for the Treatment of Patients with Predominant Negative Symptomps of Schizophrenia
1/22/2015
Business related R&D trial Central Nervous System API - CARIPRAZINE